Leandro M. Colli
Universidade de Ribeirão Preto(BR)Universidade de São Paulo(BR)Universidade Federal de São Paulo(BR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, Pituitary Gland Disorders and Treatments, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial(2023)431 cited
- → Burden of Nonsynonymous Mutations among TCGA Cancers and Candidate Immune Checkpoint Inhibitor Responses(2016)143 cited
- → Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma(2020)140 cited
- → Genome-wide association study identifies multiple risk loci for renal cell carcinoma(2017)137 cited
- → Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries(2022)135 cited
- → Landscape of Combination Immunotherapy and Targeted Therapy to Improve Cancer Management(2017)127 cited